ArticleGastro hep advances2024

Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.

Kenneth K Tanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.